Professional Overview
Olivia Ogilvie is a seasoned executive and researcher, currently serving as the Chief Executive Officer at Opo Bio. Her expertise spans biotechnology, research, and innovation, with a strong focus on industry growth and development in New Zealand.
Experience Summary
Current Role
As the Chief Executive Officer at Opo Bio, Olivia oversees the strategic direction and operations of the company. Her key responsibilities include driving business growth, fostering research collaborations, and leading cross-functional teams. Notably, she has also been a Senior Research Fellow at the University of Canterbury since 2020 and the Chair at Momentum–Powered By UniServices since 2019, demonstrating her commitment to both industry and academia.
Career Progression
Olivia's career trajectory showcases progressive growth and diverse experience. Previously, she served as a Board Observer at Ampersand Technologies, a Judge for the Feed the Next Billion Challenge at XPRIZE, and held various roles at Matū, including Iraoho Analyst and Iraoho Intern. She was also the Chief Executive Officer at Chiasma from 2018 to 2019. These roles have equipped her with a broad range of skills and insights into biotechnology, research, and innovation.
Academic Background
Olivia's highest level of education is a PhD, which she pursued at the University of Auckland from 2017 to 2020. Although specific details on her specialization and notable academic achievements are not available, her academic background in conjunction with her professional experience underscores her expertise in biotechnology and research.
Areas of Expertise
Olivia's expertise includes:
- Biotechnology and life sciences
- Research and innovation management
- Strategic leadership and team management
- Industry growth and development
Professional Impact
While specific details on notable projects, industry contributions, and measurable achievements are not provided, Olivia's multifaceted career and her current and past roles suggest a significant impact on the biotechnology and research sectors in New Zealand.
Conclusion
Olivia Ogilvie's professional trajectory is marked by leadership, innovation, and a deep commitment to biotechnology and research. Currently, she is focused on driving growth and innovation at Opo Bio, while continuing to contribute to the academic community through her role at the University of Canterbury. Her value proposition lies in her unique blend of executive leadership, research expertise, and industry knowledge, making her a pivotal figure in New Zealand's biotechnology sector.
